On Monday, General Electric Company (NYSE:GE)’s shares inclined 1.21% to $25.10.
GE Aviation will create a turboprop engine development, test and production operation in Europe. This will represent an investment surpassing $400 million and ultimately support 500 – 1,000 jobs.
The turboprop industry is highly global and comprised of many small aircraft operators. Among the factors driving GE Aviation to pursue the new operation in Europe is the need to support these and other international customers with financing through government-sponsored Export Credit Agencies (ECAs).
GE is presently bidding on $11 billion of projects that require export financing. The U.S. remains the only major economy in the world without an Export Bank. Since the U.S. Export Import Bank (Ex-Im) authorization expired July 1, GE has commenced talks with several foreign ECAs to secure financing for its customers.
General Electric Company (GE) operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment. Its Oil and Gas segment provides surface and subsea drilling and production systems, equipment for floating production platforms, compressors, turbines, turboexpanders, reactors, industrial power generation, and auxiliary equipment.
Hecla Mining Company (NYSE:HL)’s shares dropped -4.50% to $2.12.
Hecla Mining Company (HL) declared that it anticipates to start production at its San Sebastian project in the State of Durango, Mexico, by the end of 2015.
Economic Assumptions
The following is a summary of high-level life of mine economic assumptions of surface mining operations, as outlined in the Preliminary Economic Assessment (PEA) by AMC Mining Consultants (Canada) Ltd., to be accomplished within 45 days of this declarement.1,2 The numbers shown are subject to change that is not anticipated to be material.
Velardeña Mill
Hecla has secured the use of a Merrill-Crowe processing plant near Velardeña in the State of Durango, Mexico, as declared on July 15, 2015. Under the terms of the toll treatment arrangement, Hecla has the ability to use the mill for 18 months, with the potential to extend for up to another 12 months. Located within 100 miles of San Sebastian, the mill was formerly used by Hecla to process ore when it mined on the property from 2001 to 2005.
The mill has been idle for several years and is presently being rehabilitated and updated. The filling of supervisory positions is underway. The owner of the mill is in the process of reactivating existing permits.
Mining Technique
The projected mining technique focuses on shallow, near-surface pits on the East Francine, Middle and North veins, targeting high-grade material. The pits are predictable to be small, extending to a maximum of about 270 feet in depth. Near-surface material is weathered, and should be easily excavated. Drill and blast techniques are contemplated for deeper material.
The Company intends to use a contractor for mining operations, and the RFP process is progressing well.
Hecla Mining Company, together with its auxiliaries, discovers, acquires, develops, produces, and markets precious and base metal deposits worldwide. The company offers unrefined gold and silver bullion bars to precious metals traders; and lead, zinc, and bulk concentrates to custom smelters and brokers.
At the end of Monday’s trade, Juniper Networks, Inc. (NYSE:JNPR)‘s shares surged 0.86% to $25.76.
Aerohive Netoperates® (HIVE) and Juniper Netoperates (JNPR), the industry leader in network innovation, recently declared a new technology alliance to deliver a simple, secure, and cloud-managed wired and wireless solution to distributed enterprises, counting in retail, K-12 education, in addition to state and local government customer segments. Aerohive cloud Wi-Fi solutions coupled with Juniper Netoperates high performance switches, comprehensive network administration, and security solutions will assist enterprises simplify network planning, orchestration, and deployment.
The increasing consumption of applications and mobile-first access in the workplace is driving tremendous change in wireless and wired network infrastructure for recently’s distributed enterprises. Businesses face new challenges of securing the network for a diverse set of devices with effective strategies for guests, bring your own device (BYOD), and Internet of Things (IoT). At the same time, organizations need to provide a secure, scalable, and high-performance network infrastructure from the wireless edge to the core, all with shrinking IT budgets and a lack of IT expertise at enterprise branch locations.
Juniper Netoperates, Inc. designs, develops, and sells high-performance network products and services worldwide. It provides various routing products, counting ACX series universal access routers to deploy new high-bandwidth services; MX series Ethernet routers that functions as a universal edge platform; M series edge routers; PTX series packet transport routers; and T series routers.
Synthetic Biologics Inc (NYSEMKT:SYN), ended its Monday’s trading session with -5.49% loss, and closed at $3.10.
Synthetic Biologics, Inc. (SYN), a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, presented data from its novel SYN-004 program that demonstrated SYN-004 protected the gut microbiome from damage often caused by the intravenous (IV) beta-lactam antibiotic, ceftriaxone, in a pilot study of humanized pigs. The data were presented yesterday in a late-breaker oral presentation at the 2015 Interscience Conference of Antimicrobial Agents and Chemotherapy and International Congress of Chemotherapy and Infection joint meeting (ICAAC/ICC 2015) in San Diego, CA.
SYN-004 is the Company’s candidate therapy, presently in Phase 2 clinical trials, that is designed to degrade certain IV beta-lactam antibiotics within the gastrointestinal (GI) tract and maintain the natural balance of the gut microbiome for the prevention of C. difficile infection, antibiotic-associated diarrhea (AAD) and secondary antibiotic-resistant infections. C. difficile is frequently associated with IV antibiotic treatment and is the leading type of hospital attained infection accounting for more than 1.1 million infectionsi and 30,000 related deathsii each year in the United States.
Synthetics Biologics, Inc., a clinical-stage biotechnology company, develops pathogen-specific therapies for serious infections and diseases with a focus on protecting the microbiome. I
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
